Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "humanities"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
Showing
1
-
20
of
26
Search:
'"humanities"'
,
query time: 0.04s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Tocilizumab (Actemra - Hoffmann-La Roche Limited) : indication : giant cell arteritis
Published 2018
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: ankylosing spondylitis
Published 2020
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
4
CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis
Published 2020
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
5
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
6
CADTH Canadian Drug Expert Committee recommendation: Ocrelizumab (Ocrevus -- Hoffmann-La Roche Limited) : indication : treatment of adult patients with relapsing-remitting multiple...
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
7
Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
8
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
9
CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
10
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
11
CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis
Published 2017
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
...
”
Read Now
12
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
13
CADTH Canadian Drug Expert Committee final recommendation: Ixekizumab (Taltz -- Eli Lilly Canada Inc.) : indication: moderate to severe plaque psoriasis
Published 2016
Canadian Agency for Drugs and Technologies in Health
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ economics...
”
Read Now
14
CADTH Canadian Drug Expert Committee recommendation: Belimumab (Benlysta subcutaneous [SC] -- GlaxoSmithKline Inc.) : indication: systemic lupus erythematosus (SLE)
Published 2020
CADTH
Subjects:
“
...Antibodies, Monoclonal,
Humanized
/ therapeutic use...
”
Read Now
15
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
“
... of
human
immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically stable...
”
Read Now
16
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...
Published 2018
CADTH
“
... of
human
immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically stable...
”
Read Now
17
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
Read Now
18
CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...
Published 2019
CADTH
Read Now
19
CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
...Brolucizumab has a Health Canada indication for the treatment of nAMD. Brolucizumab is a
humanized
...
”
Read Now
20
CADTH Canadian Drug Expert Committee recommendation: Ofatumumab (Kesimpta -- Novartis Hharmaceuticals Canada Inc.) : indication : multiple sclerosis, relapsing-remitting
Published 2021
Canadian Agency for Drugs and Technologies in Health
“
... disease defined by clinical and imaging features. Ofatumumab is a
human
monoclonal antibody...
”
1
2
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Year of Publication
From:
To:
Classification
610 - Medicine & health
25
140 - Specific philosophical schools
17
330 - Economics
13
700 - The arts; fine & decorative arts
4
Language
English
26
Collection
National Center for Biotechnology Information
26
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
24
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&lookfor=%22humanities%22&type=AllFields
Send by Email
×
Loading...